Null and opposing effects of asian ginseng (panax ginseng c.a. meyer) on acute glycemia: results of two acute dose escalation studies

Journal of the American College of Nutrition

Volumn 22, Issue 6, 2003, Pages 524-532

  Sievenpiper, John L ^a   Arnason, John T ^b   Leiter, Lawrence A ^a   Vuksan, Vladimir ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Complementary and alternative medicine; Ginseng; Glucose; Insulin; Postprandial

Indexed keywords

GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; PROTOPANAXADIOL; PROTOPANAXATRIOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GINSENG; GINSENOSIDE RF; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPECIES DIFFERENTIATION; ULTRAVIOLET RADIATION;

ACUTE DISEASE; ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GINSENOSIDES; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; PANAX; PHYTOTHERAPY; POSTPRANDIAL PERIOD; REFERENCE VALUES; SAPONINS; SINGLE-BLIND METHOD; TIME FACTORS;

PANAX; PANAX GINSENG; PANAX QUINQUEFOLIUS;

EID: 0346887193     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2003.10719331     Document Type: Article

References (54)

1. Ryan EA, Pick ME, Marceau C: Use of alternative medicines in diabetes mellitus. Diabet Med 18:242-245, 2001.
2. Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS: Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Intern Med 162:281-287, 2002.
3. Harnack LJ, Rydell SA, Stang J: Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, metropolitan area. Mayo Clin Proc 76:688-694, 2001.
4. Angell M, Kassirer JP: Alternative Medicine—the risks of untested and unregulated remedies. N Engl J Med 339:839-841, 1998.
5. Fontanarosa PB, Lundberg GD: Alternative medicine meets science. JAMA 280:1618-1619, 1998.
6. Hoey J: The arrogance of science and the pitfalls of hope. CMAJ 159:803-804, 1998.
7. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson J-L, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25:148-198, 2002.
8. Kimuru M, Suzuki J: The pattern of action of blended Chinese traditional medicines to glucose tolerance curves in genetically diabetic mice. J Pharm Dyn 4:907-915, 1991.
9. Ohnishi Y, Takagi S, Miura T, Usami M, Kako M, Ishihara E, Yano H, Tanigawa K, Seino Y: Effect of ginseng radix on GLUT2 protein content in mouse liver in normal and epinephrine-induced hyperglycemic mice. Biol Pharm Bull 19:1238-1240, 1996.
10. Martinez B, Staba EJ: The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats. Jpn J Pharmacol 35:79-85, 1984.
11. Sotaniemi EA, Haapakoski E, Rautio A: Ginseng therapy in noninsulin-dependent diabetic patients Diabetes Care 18:1373-1375, 1995.
12. Vuksan V, Sieveniper JL, Koo VYY, Francis T, Beljan-Zdravkovic U, Xu Z, Vidgen E: American ginseng reduces postprandial glycemia in nondiabetic and diabetic individuals. Arch Intern Med 160:1009-1013, 2000.
13. Vuksan V, Stavro MP, Sievenpiper JL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Zheng Xu: Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23:1221-1226, 2000.
14. Vuksan V, Stavro MP, Sievenpiper JL, Koo VY, Wong E, Beljan-Zdravkovic U, Francis T, Jenkins AL, Leiter LA, Josse RG, Xu Z: American ginseng improves glycemia in individuals with normal glucose tolerance: Effect of dose and time escalation. J Am Coll Nutr, 19:738-744, 2000.
15. Vuksan V, Sievenpiper JL, Wong J, Xu Z, Beljan-Zdravkovic U, Arnason JT, Assinewe V, Stavro MP, Jenkins AL, Leiter LA, Francis T: American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time, but not dose, dependent manner in healthy individuals. Am J Clin Nutr 73:753-758, 2001.
16. Vuksan V, Sievenpiper JL, Xu Z, Beljan-Zdravkovic U, Jenkins AL, Arnason JT, Bateman R, Leiter LA, Josse RG, Francis T, Stavro MP: Ginseng and diabetes: A new way to use an old medicine. CJDC 25(Suppl 2):111-120, 2001.
17. Hasegawa H, Matsumiya S, Murakami C, Kurokawa T, Kasai R, Ishibashi S, Yamasaki K: Interactions of ginseng extract, ginseng separated fractions, and some triterpenoid saponins with glucose transporters in sheep erythrocytes. Planta Med 60:153-157, 1994.
18. Yokozawa T, Kobayashi T, Kawai A, Oura H, Kawashima Y: Stimulation of lipid and sugar metabolism in ginsenoside-Rb2 treated rats. Chem Pharm Bull 32:2766-2772, 1984.
19. Yokozawa T, Kobayashi T, Oura H, Kawashima Y: Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats. Chem Pharm Bull 33:869-872, 1985.
20. Xie JT, Zhou YP, Dey L, Attele AS, Wu JA, Gu M, Polonsky KS, Yuan CS: Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 9:254-258, 2002
21. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS: Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51:1851-1858, 2002.
22. Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V: Differential effects of American ginseng: A batch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affect postprandial glycemia. Eur J Clin Nutr 57:243-248, 2003.
23. Agriculture and Agri-Food Canada: The Canadian ginseng industry: Preparing for the 21st century. [article online], 2000. Available from http://atn-riae.agr.ca/info/can/e2765.htm Accessed 26 August 2002.
24. Report of a WHO Study Group: “Prevention of Diabetes Mellitus,” [WHO Technical Report, Series 844]. Geneva: World Health Organization, 1994.
25. Fitzloff JF, Yat P, Lu ZZ, Awang DVC, Arnason JT, van Breeman RB, Hall T, Blumethal M, Fong HHS: Perspectives on the quality control assurance of ginseng products in North America. In Huh H, Choi KJ, Kim YC (eds): “Advances in Ginseng Research: Proceedings of the 7th International Symposium on Ginseng.” Seoul: Korean Society of Ginseng, pp. 138-145, 1998.
26. Kadish AH, Hall DA: A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. Clin Chem 11:869-875, 1965.
27. Liverey JH, Hodgkinson SC Roud HR and Donald RA: Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin Biochem 13:151-155, 1980.
28. Wolever TMS, Jenkins DJA, Jenkins AL, Josse RG: The glycemic index: methodology and clinical implications. Am J Clin Nutr 54:846-854, 1991.
29. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglyce-mic insulin clamp. Diabetes Care 22:1462-1470, 1999.
30. Phillips DI, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-292, 1994.
31. Ma Y, Mai L, Malley L, Doucet M: Distribution and proportion of major ginsenosides and quality control of ginseng products. Chi J Med Chem 6:11-21, 1996.
32. Awang DVC: The neglected ginsenosides of North American ginseng (panax quinquefolius L.). J Herbs Spices Med Plants 7:103-109, 2000.
33. Wang X, Sakuma T, Asafu-Adjaye E, Shiu GK: Determination of ginsenosides in plant extracts from Panax ginseng and Panax quinquefolius L. by LC/MS/MS. Anal Chem 71:1579-1584, 1999.
34. Chan TWD, But PPH, Cheng SW, Kwok IMY, Lau FW, Xu HX: Differentiation and Authentication of Panax ginseng, Panax quinquefolius, and Ginseng Products by Using HPLC/MS. Analyt Chem 72:1281-1287, 2000.
35. Li W, Gu C, Zhang H, Awang DV, Fitzloff JF, Fong HH, van Breemen RB: Use of high-performance liquid chromatography-tandem mass spectrometry to distinguish Panax ginseng C. A. Meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng). Analyt Chem 72:5417-5422, 2000.
36. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus American Diabetes Association: Clinical practice recommendations 2002. Diabetes Care 25(Suppl 1):S1-S147, 2002.
37. Staba EJ, Staba JE: Ginseng (Panax species). In Chandler F (ed): “Herbs: Everyday References for Herbal Professionals.” Ottawa: Canadian Pharmacists Association and Canadian Medical Association, pp 130-135, 2000.
38. Cheng JT. Review: drug therapy in Chinese traditional medicine. J Clin Pharmacol. 40:445-450, 2000.
39. Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM: Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 73:1101-1106, 2001.
40. Han HJ, Park SH, Koh HJ, Nah SY, Shin DH, Choi HS: Proto-panaxatriol ginsenosides inhibit glucose uptake in primary cultured rabbit renal proximal tubular cells by arachidonic acid release. Kidney Blood Press Res 22:114-120, 1999.
41. Konno C, Sugimyama K, Kano M, Hikino H: Isolation and hypoglycemic activity of panaxans A, B, C, D, and E glycans of Panax ginseng roots. Planta Med 50:434-436, 1984.
42. Oshima Y, Konno C, Hikino H: Isolation and hypoglycemic aci-tivity of panaxans I, J, K, and L, glycans of Panax ginseng roots. J Ethnopharmacol 14:255-259, 1985.
43. Konno C, Murakami M, Oshima Y, Hikino H: Isolation and hypoglycemic activity of panaxans Q, R, S, T and U, glycans of Panax ginseng roots. J Ethnopharmacol 14:69-74, 1985.
44. Yamamoto A: Improvement of transmucosal absorption of biologically active peptide drugs. Yakugaku Zasshi 121:929-948, 2001.
45. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280:1569-1575, 1998.
46. Yokozawa T, Seno H, Oura H: Effect of Ginseng extract on lipid and sugar metabolism. I. Metabolic correlation between liver and adipose tissue. Chem Pharm Bull 23:3095-3100, 1975.
47. Kimura M, Isami W, Tanaka O, Nagi Y, Shibita S: Pharmacological sequential trials for the fraction of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix. J Pharm Dyn 4:402-409, 1981.
48. Kimura M, Waki I, Chujo T, Kikuchi T, Hiyama C, Yamazaki K, Tanaka O: Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and one insulin release from perfused rat pancreas. J Pharm Dyn 4:410-417, 1981.
49. Joo CN, Kim JH: Study on the hypoglycemic action of ginseng saponin on streptozotocin diabetic rats. Korean J Ginseng Sci 16:190-197, 1992.
50. Martinez B, Staba EJ: The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats. Jpn J Pharmacol 35:79-85, 1984.
51. Chung SH, Choi CG, Park SH: Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch Pharm Res 24:214-218, 2001.
52. Choi SR, Saji H, Iida Y, Magata Y, Yokoyama A: Ginseng pretreatment protects against transient global cerebral ischemia in the rat: measurement of local cerebral glucose utilization by [14C]deoxyglucose autoradiography. Biol Pharm Bull 19:644-646, 1996.
53. Sievenpiper JL, Arnson JT, Assinewe V, Di Buono M, Vuksan V: Chinese ginseng (Panax ginseng CA Meyer) within a low dose range does not affect postprandial glycemia in subjects with normal glucose tolerance. FASEB 15: A632-A632, 2001.
54. Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V: Asian ginseng within a high dose range increases glycemia: Implications for safety. Diabetes 51(Suppl 2):A403, 2002